The human T-cell lymphotropic virus type 1 (HTLV-1) is a deltaretrovirus claimed to be
aetiologically linked to the adult T-cell leukaemia/lymphoma (ATLL) and associated …

Human T-lymphotropic virus 1 (HTLV-1) affects 5–10 million individuals worldwide. Most of
those infected with this virus remain asymptomatic; however, 0.25%–4% of individuals …

It has been more than 30 years since the discovery of human T‐lymphotropic virus type 1
(HTLV‐1), the first human retrovirus identified. Human T‐lymphotropic virus type 1 infects 15 …

Human T-cell leukemia virus type-1 (HTLV-1) causes two distinct diseases, adult T-cell
leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis …

Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a neural chronic
inflammation, called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) …

Human T lymphotropic Virus type 1 (HTLV-1) is the etiological agent of Adult T cell
Leukemia/Lymphoma (ATLL) and HTLV-1-Associated Myelopathy/Tropical Spastic …

Human T‐cell leukemia virus type 1 (HTLV‐1) was discovered in the 1980s, but it is
estimated to have been infecting humans for more than ten thousand years. 1 With over 90 …

The human T-cell leukemia virus type 1 (HTLV-1) is the only known human oncogenic
retrovirus. HTLV-1 can cause a type of cancer called adult T-cell leukemia/lymphoma (ATL) …

Human T-cell leukemia virus type 1 (HTLV-1), the first reported human oncogenic retrovirus,
is the etiologic agent of highly aggressive, currently incurable diseases such as adult T-cell …

Analysis of human T‐cell leukemia virus type 1 (HTLV‐1)‐infected cell types and the
interplay of these infected cells in vivo should provide valuable information to elucidate the …